Homeopathic Community Responds to BJM Article on Reporting Bias

By Mark Land, AAHP President   You may have seen recent reports about a new study claiming that most homeopathic research is of poor quality, with positive results overestimated. AAHP members should be aware of this study, published on March 15 in BMJ Evidence-Based Medicine. An insightful response from Homeopathy readm more…

Read More

Homeopathic Human Growth Hormone and the Illegal Risks

by Eric L. Foxman, AAHP Secretary, Pharm. (Ret.)   A quick scan of the internet shows that consumers can readily purchase over-the-counter products that allegedly contain homeopathic Human Growth Hormone (HGH). AAHP wants to remind all manufacturers, repackers, distributors, and marketers that these products are illegal and subject those involved readm more…

Read More

AAHP Supports CDC Recommendations for COVID-19

MILWAUKIE, Ore. — The American Association of Homeopathic Pharmacists (AAHP), representing the major manufacturers and distributors of homeopathic drugs, confirms that it is unaware of any homeopathic literature or clinical trial that specifically support the use of any homeopathic drug for prevention or treatment of the 2019 Novel Coronavirus and readm more…

Read More

FDA Comment Period Extended: Help AAHP Present Manufacturers’ Voice

AAHP is preparing comments to “FDA Drug Products Labeled as Homeopathic; Draft Guidance for Food and Drug Administration Staff and Industry.” Initially published in December 2017, the guidance was revised and republished in October 2019. FDA has now extended the comment period to March 23. AAHP victoriously requested that key elements of the 1988 readm more…

Read More

AAHP’s Views on Aspects of FDA’s Revised Draft Guidance

Since 2015, the Food and Drug Administration (FDA) has been engaged in a reevaluation of Compliance Policy Guide 400.400, Conditions under Which Homeopathic Drugs May Be Marketed. FDA issued a new draft policy in December 2017, and, after a public comment period, it issued a revised draft in October 2019, readm more…

Read More

Consumer Advertising and Labeling Guideline for Over-the-Counter Homeopathic Medicines

Adopted August 22, 2012 Revised August 29, 2017 Introduction Homeopathic medicines play an increasing role in self-medication among American consumers. Homeopathic products sold at retail provide consumers with access to low cost, safe medications, and they are routinely marketed to consumers on retail shelves among other well known OTC products. readm more…

Read More

Consideration of Homeopathic Medicine as a Vaccine Alternative

 Milwaukie, Ore., Autumn 2015—As the public debate on vaccinations rises, more healthcare providers and parents alike seek information. The American Association Homeopathic Pharmacists (AAHP) reminds manufacturers and marketers that the promotion of any product—homeopathic or otherwise—as an over-the-counter alternative to a vaccine is a violation of federal and state law. Furthermore, in readm more…

Read More

Experts Discuss Advertising of Homeopathic Medicines at FTC Workshop

Washington, D.C., Sept. 22, 2015—Trade association leaders, experts in consumer marketing and regulations, and top physicians came together on Monday, September 21 in Washington, D.C. at “Homeopathic Medicine & Advertising: A Federal Trade Commission (FTC) Workshop.” President of the American Association of Homeopathic Pharmacists (AAHP) Mark Land stated, “We have readm more…

Read More

Homeopathic Industry Proposes More Broad Use of Disclosures to FTC as the Path Forward

Industry leaders provide perspective on partnership opportunities for Federal Trade Commission Washington, D.C., Sept. 21, 2015— To better help consumers make informed choices, the American Association of Homeopathic Pharmacists (AAHP) proposed strengthening product label and advertising disclosures to the Federal Trade Commission (FTC) today in Washington, D.C. at the agency’s readm more…

Read More